Brendan Frett

University of Arkansas for Medical Sciences

MedicineChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases”.

Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases

Scientific Reports(2021)10.1038/s41598-021-95612-4

N/A

0.442DataRank · unranked

18 citations

Donglin Yang, Naga Rajiv Lakkaniga, Brendan Frett, Nicholas McConnell, Lingtian Zhang +8 more

Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of RET: Design, synthesis and biological evaluation

European Journal of Medicinal Chemistry(2020)10.1016/j.ejmech.2020.112691

N/A

0DataRank · unranked

29 citations

Gunaganti Naresh, Lingtian Zhang, Binyam Belachew, Brendan Frett, Yuet‐Kin Leung +2 more

Discovery of imidazo[1,2-a]pyridine-thiophene derivatives as FLT3 and FLT3 mutants inhibitors for acute myeloid leukemia through structure-based optimization of an NEK2 inhibitor

European Journal of Medicinal Chemistry(2021)10.1016/j.ejmech.2021.113776

N/A

0DataRank · unranked

23 citations

Naga Rajiv Lakkaniga, Jaideep B. Bharate, Nicholas McConnell, Xiuqi Wang, Anupreet Kharbanda +5 more

Discovery and biological evaluation of phthalazines as novel non-kinase TGFβ pathway inhibitors

European Journal of Medicinal Chemistry(2021)10.1016/j.ejmech.2021.113660

N/A

0DataRank · unranked

4 citations

Lingtian Zhang, Debasmita Saha, Phuc Tran, Ke Xu, Ming O. Li +4 more

Discovery of 4-aminoquinolines as highly selective TGFβR1 inhibitors with an attenuated MAP4K4 profile for potential applications in immuno-oncology

European Journal of Medicinal Chemistry(2021)10.1016/j.ejmech.2021.113763

N/A

0DataRank · unranked

4 citations

Phuc Tran, Lingtian Zhang, Yuet‐Kin Leung, Hongyu Li, Brendan Frett +1 more

Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules

RSC Medicinal Chemistry(2023)10.1039/d3md00457k

N/A

0DataRank · unranked

16 citations

Debasmita Saha, Daniel W. Armstrong, Baha’a Jabali, Maha Hanafi, Alan Herrera-Rueda +3 more

Enhancer‐activated RET confers protection against oxidative stress to KMT2A‐rearranged acute myeloid leukemia

Cancer Science(2024)10.1111/cas.16069

N/A

0DataRank · unranked

9 citations

Kimberly Stephens, Brian Koss, Stepan Melnyk, Jason E. Farrar, Debasmita Saha +2 more

Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441

Scientific Reports(2024)10.1038/s41598-024-70858-w

N/A

0DataRank · unranked

3 citations

Baku Acharya, Daniel W. Armstrong, Maha Hanafi, Randall R Rainwater, Sharon Amole +7 more

Transforming growth factor β receptor 1 and mitogen-activated protein 4 kinase 4 dual inhibitor, TK-850, reduces renal fibrosis in unilateral ureteral–obstructed mice

Journal of Pharmacology and Experimental Therapeutics(2025)10.1016/j.jpet.2025.103644

N/A

0DataRank · unranked

0 citations

Samaneh Goorani, Abhishek Mishra, Abdul H. Khan, Baku Acharya, Brendan Frett +2 more

ProteoViz: a tool for the analysis and interactive visualization of phosphoproteomics data

Molecular Omics(2020)10.1039/c9mo00149b

N/A

0DataRank · unranked

30 citations

Kevin Naceanceno, Renny S. Lan, Charity L. Washam, Lisa Orr, Samuel G. Mackintosh +8 more

Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors

European Journal of Medicinal Chemistry(2025)10.1016/j.ejmech.2025.118145

N/A

0DataRank · unranked

0 citations

Maha Hanafi, Luke Enemark, Daniel W. Armstrong, Debasmita Saha, Sayem Miah +2 more